We are live on ! Find out more
SC

Schiavi & Co Portfolio holdings

AUM $337M
1-Year Est. Return 16.69%
This Fund
S&P 500
This Quarter Est. Return
-0.21%
1 Year Est. Return
+16.69%
3 Year Est. Return
+32.96%
5 Year Est. Return
+28.88%
10 Year Est. Return
AUM
$255M
AUM Growth
+$1.29M
Cap. Flow
+$1.99M
Cap. Flow %
0.78%
Top 10 Hldgs %
96.68%
Holding
37
New
3
Increased
11
Reduced
8
Closed
3
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VEU icon
26
Vanguard FTSE All-World ex-US ETF
VEU
$64.8B
$265K 0.1%
4,519
XOM icon
27
ExxonMobil
XOM
$650B
$264K 0.1%
2,294
IBM icon
28
IBM
IBM
$213B
$234K 0.09%
1,351
CTVA icon
29
Corteva
CTVA
$60.5B
$232K 0.09%
4,301
IVV icon
30
iShares Core S&P 500 ETF
IVV
$858B
$231K 0.09%
423
+33
+8% +$17.4K
GMED icon
31
Globus Medical
GMED
$11.1B
$205K 0.08%
+3,000
New +$179K
OKE icon
32
Oneok
OKE
$56.7B
$201K 0.08%
+2,468
New +$197K
NVDA icon
33
NVIDIA
NVDA
$4.6T
$200K 0.08%
+1,620
New +$164K
SSP icon
34
E.W. Scripps
SSP
$270M
$56.8K 0.02%
18,087
AZN icon
35
AstraZeneca
AZN
$269B
-5,686
Closed -$770K
COP icon
36
ConocoPhillips
COP
$144B
-1,583
Closed -$202K
VXF icon
37
Vanguard Extended Market ETF
VXF
$30B
-1,284
Closed -$225K

Similar funds

Schiavi & Co's Q2 2024 Portfolio in Review

As of Q2 2024, Schiavi & Co held 37 positions worth $255M, up 0.51% from $254M the previous quarter. Its ten largest holdings account for 97% of the portfolio.

Schiavi & Co's Q2 2024 filing shows 3 new, 11 increased, 8 reduced and 3 closed positions. Its largest new stake was Oneok: 2,468 shares worth $201K. The largest sale was PIMCO RAFI Dynamic Multi-Factor US Equity ETF, an estimated $867K.

By sector, the portfolio is most concentrated in Technology at 0.72% of assets, up from 0.45% a quarter earlier, followed by Healthcare and Financials.

  • Schiavi & Co's largest Q2 2024 buy was Oneok: 2,468 shares worth $201K.
  • Schiavi & Co added most to Vanguard Short-Term Treasury ETF in Q2 2024, an estimated $1.55M increase.
  • Schiavi & Co's biggest Q2 2024 reduction was PIMCO RAFI Dynamic Multi-Factor US Equity ETF, cutting an estimated $867K.
  • Schiavi & Co fully exited AstraZeneca in Q2 2024, selling an estimated $770K.
  • Schiavi & Co's ten largest holdings make up 97% of its $255M portfolio in Q2 2024.
  • Schiavi & Co opened 3 new positions and closed 3 in Q2 2024.
  • Schiavi & Co's portfolio value rose 0.51% quarter-over-quarter to $255M.

Based on Schiavi & Co's 13F filing for Q2 2024, filed 8 Aug 2024.